Estimating the minimum important change in the 15D scores

Quality of Life Research

Volumn 24, Issue 3, 2015, Pages 599-606

  Alanne, Soili ^a   Roine, Risto P ^b,c   Räsänen, Pirjo ^b   Vainiola, Tarja ^b   Sintonen, Harri ^d  

^a SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^b HOSPITAL DISTRICT OF HELSINKI AND UUSIMAA   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

15D; Global assessment scale; Health related quality of life; Minimum clinically important difference; Minimum important change

Indexed keywords

FEMALE; FINLAND; FOLLOW UP; HEALTH STATUS; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

FEMALE; FINLAND; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; QUALITY OF LIFE; QUESTIONNAIRES; RESEARCH DESIGN; ROC CURVE; SURVEYS AND QUESTIONNAIRES;

EID: 85028170991     PISSN: 09629343     EISSN: 15732649     Source Type: Journal    
DOI: 10.1007/s11136-014-0787-4     Document Type: Article

References (31)

1. Jaeshke, R., Singer, J., & Guyatt, G. (1989). Measurement of health status. Ascertaining the minimal clinically important difference. Controlled Clinical Trials,10, 407–415.
2. Guyatt, G. H., Osoba, D., Wu, A. W., Wyrwich, K., & Norman, G. (2002). Methods to explain the clinical significance of health status measures. Mayo Clinic Proceedings,77, 371–383.
3. King, M. T. (2011). A point of minimal important difference (MID): A critique of terminology and methods. Expert Expert review of Pharmacoeconomics and Outcomes Research,11(2), 171–184.
4. Beaton, D. E., Bombardier, C., Katz, J. N., Wright, J. G., Wells, G., Boers, M., et al. (2001). Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome measures in rheumatology. Minimal clinically important difference. The Journal of Rheumatology,28, 400–405.
5. de Vet, H. C., Beckerman, H., Terwee, C. B., Terluin, B., & Bouter, L. M. (2006). Definition of clinical differences. The Journal of Rheumatology,33, 434.
6. de Vet, H. C., & Terwee, C. B. (2010). The minimal detectable change should not replace the minimal important difference. Journal of Clinical Epidemiology,63, 804–805.
7. Gatchel, R. J., Mayer, T. G., & Chou, R. (2012). What does/should the minimum clinically important difference measure? A reconsideration of its clinical value in evaluating efficacy of lumbar fusion surgery. The Clinical Journal of Pain,28(5), 387–396.
8. Lydick, E., & Epstein, R. S. (1993). Interpretation of quality of life changes. Quality of Life Research,2, 221–226.
9. Cohen, J. (1988). Statistical power analysis for the behavioural sciences. Hillsdale: Lawrence Erlbaum Associates.
10. Norman, G., Sloan, J., & Wyrwich, K. (2003). Interpretation of changes in health-related quality of life. The remarkable universality of half a standard deviation. Medical Care,41(5), 582–592.
11. Jakobson, N., & Truaux, P. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology,59(1), 12–19.
12. Wyrwich, K. W., Tierney, W. M., & Wolinsky, F. D. (1999). Further evidence supporting an SEM-based criterion for indentifying meaningful intra-individual changes in health-related quality of life. Journal of Clinical Epidemiology,52(9), 861–873.
13. Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2004). An integrated method to determine meaningful changes in health-related quality of life. Journal of Clinical Epidemiology,57, 1153–1160.
14. de Vet, H. C., Ostelo, R. W. J. D., Terwee, C., van der Roer, N., Knol, D., Beckerman, H., et al. (2007). Minimally important change determined by a visual method integrating an anchor-based and distribution-based approach. Quality of Life Research,16, 131–142.
15. Walters, S. J., & Brazier, J. E. (2003). What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health and Quality of Life Outcomes,1, 4.
16. Walters, S. J., & Brazier, J. E. (2005). Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Quality of Life Research,14, 1523–1532.
17. Pickard, A. S., Neary, M. P., & Cella, D. (2007). Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health and Quality of Life Outcomes,5, 70.
18. Wiebe, S., Matijevic, S., Eliasziw, M., & Derry, P. A. (2002). Clinically important change in quality of life in epilepsy. Journal of Neurology, Neurosurgery and Psychiatry,73, 116–120.
19. Sintonen, H. (1994). Outcome measurement in acid-related diseases. Pharmacoeconomics,5(suppl. 3), 17–26.
20. Sintonen, H. (1994).The 15D-measure of health-related quality of life. I. Reliability, validity and sensitivity of its health state descriptive system. Working Paper 41. Melbourne: Centre for Health Program Evaluation. (http://www.buseco.monash.edu.au/centres/che/pubs/wp41.pdf).
21. Sintonen, H. (1995). The 15D-measure of health-related quality of life. II. Feasibility, reliability and validity of its valuation system, Working Paper 42. Melbourne: Centre for Health Program Evaluation 1995. (http://www.buseco.monash.edu.au/centres/che/pubs/wp42.pdf).
22. Sintonen, H. (2001). The 15D instrument of health-related quality of life: Properties and applications. Annals of Medicine,33, 328–336.
23. 15D instrument: http://www.15d-instrument.net/15d. Accessed 2 June 2014.
24. Wheaton, L., & Pope, J. (2010). The minimally important difference for patient-reported outcomes in spondyloarthropathies including pain, fatigue, sleep and Health Assessment Questionnaire. The Journal of Rheumatology,37(4), 816–822.
25. Kwok, T., & Pope, J. E. (2010). Minimally important difference for patient-reported outcomes in psoriatic arthritis: Health Assessment Questionnaire and pain, fatigue and global visual analog scales. The Journal of Rheumatology,37(5), 1024–1028.
26. Santanello, N. C., Zhang, J., Seidenberg, B., Reiss, T. F., & Barber, B. L. (1999). What are minimal important changes for asthma measures in a clinical trial? European Respiratory Journal,14, 23–27.
27. Fayers, P. M., & Hays, R. D. (2014). Don’t middle your MIDs: Regression to the mean shrinks estimates of minimally important differences. Quality of Life Research,23, 1–4.
28. Copay, A., Subach, B., Glassman, S., Polly, D., & Schuler, T. (2007). Understanding the minimum clinically important difference: A review of concepts and methods. The Spine Journal,7, 541–546.
29. Åberg, F., Rissanen, A. M., Sintonen, H., Roine, R. P., Höckerstedt, K., & Isoniemi, H. (2009). Health-related quality of life and employment status of liver transplant patients. Liver Transplantation,15(1), 64–72.
30. McClimans, L. (2011). Interpretability, validity, and the minimum important difference. Theoretical Medicine and Bioethics,32, 389–401.
31. Wyrwich, K. W., & Tardino, V. M. (2006). Understanding global transition assessments. Quality of Life Research,15, 995–1004.